The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism
- PMID: 25404119
- DOI: 10.1007/s00281-014-0464-2
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism
Abstract
An increased understanding of the importance of microbiota in shaping the host's immune and metabolic activities has rendered fungal interactions with their hosts more complex than previously appreciated. It is now clear that a three-way interaction between host, fungi, and microbiota dictates the types of host-fungus relationship. Indeed, microbial dysbiosis predisposes to a variety of chronic fungal infections and diseases at local and distant sites. By correlating changes in metabolite profiles with microbiota metagenomic composition, we have defined a functional node whereby certain bacteria species contribute to host-fungal symbiosis and mucosal homeostasis. A tryptophan catabolic pathway is exploited by commensal lactobacilli and the mammalian host to increase fitness in response to Candida albicans by inducing resistance and tolerance mechanisms of antifungal immunity. Much like lactobacilli in the gut, Firmicutes change significantly in the airways during aspergillosis. The aryl hydrocarbon receptor has a pivotal role in connecting tryptophan catabolism by microbial communities and the host's own pathway of tryptophan degradation through the enzyme indoleamine 2,3-dioxygenase 1. These data suggest that the study of the human microbiota in the trans-omics era, with a focus on metagenomics and metabonomics, is providing novel insights into the regulation of host immune responsiveness to fungi.
Similar articles
-
Learning from other diseases: protection and pathology in chronic fungal infections.Semin Immunopathol. 2016 Mar;38(2):239-48. doi: 10.1007/s00281-015-0523-3. Epub 2015 Sep 17. Semin Immunopathol. 2016. PMID: 26382631 Review.
-
Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi.Eur J Immunol. 2014 Nov;44(11):3192-200. doi: 10.1002/eji.201344406. Epub 2014 Oct 20. Eur J Immunol. 2014. PMID: 25256754 Review.
-
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases.Virulence. 2017 Aug 18;8(6):673-684. doi: 10.1080/21505594.2016.1257458. Epub 2016 Nov 7. Virulence. 2017. PMID: 27820674 Free PMC article. Review.
-
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.Immunity. 2013 Aug 22;39(2):372-85. doi: 10.1016/j.immuni.2013.08.003. Immunity. 2013. PMID: 23973224
-
Antifungal innate immunity: recognition and inflammatory networks.Semin Immunopathol. 2015 Mar;37(2):107-16. doi: 10.1007/s00281-014-0467-z. Epub 2014 Dec 20. Semin Immunopathol. 2015. PMID: 25527294 Review.
Cited by
-
Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.Cytokine. 2015 Nov;76(1):42-52. doi: 10.1016/j.cyto.2015.07.025. Epub 2015 Aug 11. Cytokine. 2015. PMID: 26276374 Free PMC article. Review.
-
Probiotics for Oral Candidiasis: Critical Appraisal of the Evidence and a Path Forward.Front Oral Health. 2022 Apr 14;3:880746. doi: 10.3389/froh.2022.880746. eCollection 2022. Front Oral Health. 2022. PMID: 35495563 Free PMC article. Review.
-
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.BMC Immunol. 2017 Jan 6;18(1):2. doi: 10.1186/s12865-016-0187-3. BMC Immunol. 2017. PMID: 28061847 Free PMC article. Review.
-
Assessment of the nasal microbiota in dogs with fungal rhinitis before and after cure and in dogs with chronic idiopathic rhinitis.BMC Microbiol. 2023 Apr 15;23(1):104. doi: 10.1186/s12866-023-02828-7. BMC Microbiol. 2023. PMID: 37061685 Free PMC article.
-
Aspergillus fumigatus and Aspergillosis in 2019.Clin Microbiol Rev. 2019 Nov 13;33(1):e00140-18. doi: 10.1128/CMR.00140-18. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31722890 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials